Rasalect 1mg

📋 Product Overview Table

🧬 What is Rasalect 1 mg?

Rasalect 1 mg is a prescription medication used for the management of Parkinson’s disease, especially to control motor symptoms such as stiffness, tremors, and difficulty with movement. The active compound, Rasagiline, is a selective monoamine oxidase-B (MAO-B) inhibitor, which helps increase dopamine levels in the brain.

Manufactured by Sun Pharmaceutical Industries Ltd., Rasalect is used both as monotherapy in early Parkinson’s and in combination with Levodopa in later stages. It works by slowing down the breakdown of dopamine, thereby enhancing its availability and improving motor control.

This medication is often prescribed to reduce motor fluctuations and extend the on-time in patients already receiving Levodopa. Its once-daily dosage and good tolerance profile make it a preferred option for long-term management.

🎬 Educational Video Placeholder

🩺 Doctor’s Expert Commentary

Dr. Arvind Ghosh, Senior Neurologist:
“Rasalect 1 mg has proven to be highly effective in early-stage Parkinson’s disease and a valuable adjunct in advanced stages. It is well-tolerated and contributes to reduced Levodopa dosage over time.”

💉 Dosage & Administration

Avoid use with other MAO inhibitors or antidepressants without doctor approval.

⚠️ Side Effects, Warnings & Storage

• Common Side Effects: Headache, joint pain, indigestion, flu symptoms
• Serious Risks: Serotonin syndrome (if combined with SSRIs/SNRIs), hallucinations
• Cautions: Avoid tyramine-rich foods (aged cheese, cured meats), monitor for mood changes
• Storage: Store below 25°C in a dry, light-protected place

🌍 Global Availability

🔗 Related Indian Alternatives (Same Therapeutic Category)

📚 Trusted Medical References

• Drugs.com – Rasagiline Monograph
• NHS – Parkinson’s Disease Info
• Sun Pharmaceutical Official Site

⚠️ Medical Disclaimer
This content is for educational purposes only. Please consult a licensed physician before starting or changing any medication.